Maven Securities LTD Purchases 16,000 Shares of Bruker Co. (NASDAQ:BRKR)

Maven Securities LTD raised its holdings in Bruker Co. (NASDAQ:BRKR) by 400.0% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 20,000 shares of the medical research company’s stock after acquiring an additional 16,000 shares during the quarter. Maven Securities LTD’s holdings in Bruker were worth $1,276,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in BRKR. Rise Advisors LLC bought a new stake in shares of Bruker in the first quarter valued at about $27,000. Covestor Ltd grew its stake in shares of Bruker by 139.1% in the first quarter. Covestor Ltd now owns 361 shares of the medical research company’s stock valued at $34,000 after acquiring an additional 210 shares in the last quarter. First Horizon Advisors Inc. grew its position in Bruker by 120.4% during the second quarter. First Horizon Advisors Inc. now owns 399 shares of the medical research company’s stock worth $25,000 after buying an additional 218 shares in the last quarter. Neo Ivy Capital Management acquired a new position in Bruker in the fourth quarter valued at about $30,000. Finally, EverSource Wealth Advisors LLC lifted its holdings in shares of Bruker by 40.7% during the 1st quarter. EverSource Wealth Advisors LLC now owns 858 shares of the medical research company’s stock worth $81,000 after acquiring an additional 248 shares during the period. Institutional investors own 79.52% of the company’s stock.

Analyst Ratings Changes

BRKR has been the topic of several recent research reports. TD Cowen cut their target price on shares of Bruker from $74.00 to $72.00 and set a “hold” rating on the stock in a research report on Wednesday, August 7th. The Goldman Sachs Group dropped their target price on shares of Bruker from $72.00 to $60.00 and set a “sell” rating on the stock in a research report on Tuesday, July 9th. Citigroup lowered their target price on Bruker from $95.00 to $80.00 and set a “buy” rating on the stock in a research report on Wednesday, July 10th. Wolfe Research downgraded Bruker from an “outperform” rating to a “peer perform” rating in a research note on Monday. Finally, Wells Fargo & Company began coverage on Bruker in a research report on Tuesday, August 27th. They issued an “overweight” rating and a $78.00 price objective on the stock. One analyst has rated the stock with a sell rating, four have given a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat, Bruker has a consensus rating of “Hold” and a consensus price target of $81.40.

Bruker Stock Down 3.3 %

BRKR stock opened at $66.76 on Wednesday. The stock has a market cap of $9.70 billion, a P/E ratio of 24.28, a PEG ratio of 2.43 and a beta of 1.18. The company has a quick ratio of 0.75, a current ratio of 1.65 and a debt-to-equity ratio of 1.18. The business’s 50-day moving average price is $65.29 and its 200-day moving average price is $71.48. Bruker Co. has a twelve month low of $53.79 and a twelve month high of $94.86.

Bruker (NASDAQ:BRKR) last released its quarterly earnings results on Tuesday, August 6th. The medical research company reported $0.52 earnings per share for the quarter, meeting the consensus estimate of $0.52. Bruker had a return on equity of 24.92% and a net margin of 11.29%. The business had revenue of $800.70 million during the quarter, compared to analysts’ expectations of $799.44 million. During the same quarter last year, the business posted $0.50 EPS. The firm’s revenue for the quarter was up 17.4% compared to the same quarter last year. On average, equities research analysts forecast that Bruker Co. will post 2.61 EPS for the current year.

Bruker Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, September 16th. Shareholders of record on Monday, September 2nd were given a dividend of $0.05 per share. This represents a $0.20 dividend on an annualized basis and a yield of 0.30%. The ex-dividend date of this dividend was Friday, August 30th. Bruker’s dividend payout ratio (DPR) is presently 7.27%.

About Bruker

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.